You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

ZIOPTAN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Zioptan, and what generic alternatives are available?

Zioptan is a drug marketed by Thea Pharma and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has eighty patent family members in twenty-six countries.

The generic ingredient in ZIOPTAN is tafluprost. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tafluprost profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Zioptan

A generic version of ZIOPTAN was approved as tafluprost by MICRO LABS on August 19th, 2019.

  Try a Trial

Paragraph IV (Patent) Challenges for ZIOPTAN
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
ZIOPTAN Ophthalmic Solution tafluprost 0.0015% 202514 2 2016-02-10

US Patents and Regulatory Information for ZIOPTAN

ZIOPTAN is protected by two US patents.

Patents protecting ZIOPTAN

Method and composition for treating ocular hypertension and glaucoma
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION

Method and composition for treating ocular hypertension and glaucoma
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Thea Pharma ZIOPTAN tafluprost SOLUTION/DROPS;OPHTHALMIC 202514-001 Feb 10, 2012 AT RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Thea Pharma ZIOPTAN tafluprost SOLUTION/DROPS;OPHTHALMIC 202514-001 Feb 10, 2012 AT RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZIOPTAN

When does loss-of-exclusivity occur for ZIOPTAN?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Argentina

Patent: 1937
Estimated Expiration: ⤷  Try a Trial

Patent: 0961
Estimated Expiration: ⤷  Try a Trial

Australia

Patent: 09252210
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 0913109
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 24194
Estimated Expiration: ⤷  Try a Trial

Patent: 65185
Estimated Expiration: ⤷  Try a Trial

China

Patent: 2083413
Estimated Expiration: ⤷  Try a Trial

Croatia

Patent: 0140979
Estimated Expiration: ⤷  Try a Trial

Patent: 0170769
Estimated Expiration: ⤷  Try a Trial

Patent: 0200998
Estimated Expiration: ⤷  Try a Trial

Patent: 0220361
Estimated Expiration: ⤷  Try a Trial

Cyprus

Patent: 15565
Estimated Expiration: ⤷  Try a Trial

Patent: 20351
Estimated Expiration: ⤷  Try a Trial

Denmark

Patent: 06977
Estimated Expiration: ⤷  Try a Trial

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

Eurasian Patent Organization

Patent: 3661
Estimated Expiration: ⤷  Try a Trial

Patent: 1071413
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 27638
Estimated Expiration: ⤷  Try a Trial

Patent: 06977
Estimated Expiration: ⤷  Try a Trial

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

Patent: 35656
Estimated Expiration: ⤷  Try a Trial

Patent: 89446
Estimated Expiration: ⤷  Try a Trial

Georgia, Republic of

Patent: 0156220
Estimated Expiration: ⤷  Try a Trial

Hungary

Patent: 33103
Estimated Expiration: ⤷  Try a Trial

Patent: 49923
Estimated Expiration: ⤷  Try a Trial

Patent: 58079
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 48317
Estimated Expiration: ⤷  Try a Trial

Patent: 56868
Estimated Expiration: ⤷  Try a Trial

Patent: 49992
Estimated Expiration: ⤷  Try a Trial

Patent: 89789
Estimated Expiration: ⤷  Try a Trial

Patent: 65584
Estimated Expiration: ⤷  Try a Trial

Patent: 11521943
Estimated Expiration: ⤷  Try a Trial

Patent: 14133765
Estimated Expiration: ⤷  Try a Trial

Patent: 16065095
Estimated Expiration: ⤷  Try a Trial

Patent: 17178957
Estimated Expiration: ⤷  Try a Trial

Patent: 18154656
Estimated Expiration: ⤷  Try a Trial

Patent: 20073574
Estimated Expiration: ⤷  Try a Trial

Patent: 21120412
Estimated Expiration: ⤷  Try a Trial

Patent: 23085558
Estimated Expiration: ⤷  Try a Trial

Jordan

Patent: 39
Estimated Expiration: ⤷  Try a Trial

Lithuania

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

Malaysia

Patent: 9463
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 10012987
Estimated Expiration: ⤷  Try a Trial

Poland

Patent: 06977
Estimated Expiration: ⤷  Try a Trial

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

Portugal

Patent: 06977
Estimated Expiration: ⤷  Try a Trial

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

Singapore

Patent: 1628
Estimated Expiration: ⤷  Try a Trial

Slovenia

Patent: 06977
Estimated Expiration: ⤷  Try a Trial

Patent: 72249
Estimated Expiration: ⤷  Try a Trial

Patent: 05334
Estimated Expiration: ⤷  Try a Trial

Patent: 14877
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 1650006
Estimated Expiration: ⤷  Try a Trial

Patent: 1820816
Estimated Expiration: ⤷  Try a Trial

Patent: 1988642
Estimated Expiration: ⤷  Try a Trial

Patent: 2114401
Estimated Expiration: ⤷  Try a Trial

Patent: 2246598
Estimated Expiration: ⤷  Try a Trial

Patent: 110011707
Estimated Expiration: ⤷  Try a Trial

Patent: 160102319
Estimated Expiration: ⤷  Try a Trial

Patent: 180008905
Estimated Expiration: ⤷  Try a Trial

Patent: 190067272
Estimated Expiration: ⤷  Try a Trial

Patent: 200057801
Estimated Expiration: ⤷  Try a Trial

Spain

Patent: 95316
Estimated Expiration: ⤷  Try a Trial

Patent: 27837
Estimated Expiration: ⤷  Try a Trial

Patent: 08050
Estimated Expiration: ⤷  Try a Trial

Patent: 07982
Estimated Expiration: ⤷  Try a Trial

Taiwan

Patent: 32202
Estimated Expiration: ⤷  Try a Trial

Patent: 1000104
Estimated Expiration: ⤷  Try a Trial

Ukraine

Patent: 2257
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering ZIOPTAN around the world.

Country Patent Number Title Estimated Expiration
South Korea 101650006 ⤷  Try a Trial
Austria 225770 ⤷  Try a Trial
China 1187486 ⤷  Try a Trial
Georgia, Republic of P20156220 COMPOSITION TREATING OCULAR HYPERTENSION AND GLAUCOMA, AND USAGE THEREOF ⤷  Try a Trial
Slovenia 2306977 ⤷  Try a Trial
Slovenia 2772249 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for ZIOPTAN

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0850926 C00850926/01 Switzerland ⤷  Try a Trial PRODUCT NAME: TAFLUPROST; REGISTRATION NO/DATE: SWISSMEDIC 60548 27.01.2010
0850926 300407 Netherlands ⤷  Try a Trial 300407, 20171222, EXPIRES: 20221221
0850926 CA 2008 00041 Denmark ⤷  Try a Trial
0850926 11C0020 France ⤷  Try a Trial PRODUCT NAME: TAFLUPROST; REGISTRATION NO/DATE IN FRANCE: CIS:6 000 728 O DU 20110328; REGISTRATION NO/DATE AT EEC: 43230 DU 20080430
0850926 91943 Luxembourg ⤷  Try a Trial 91943, EXPIRES: 20221222
0850926 SPC013/2011 Ireland ⤷  Try a Trial SPC013/2011: 20110808, EXPIRES: 20221221
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.